Zennova Pharmaceuticals(Chengdu)Co.,Ltd

About Zennova Pharmaceuticals(Chengdu)Co.,Ltd

Zennova Pharma Group is an innovation-driven multinational offering one‑stop CRDMO+S services—R&D, manufacturing, sales, and market management. With its complex formulation platform and FDA/EMA/China GMP‑compliant facilities, it accelerates the entire path from development to launch. Its proven overseas sales and operational capabilities support Chinese pharmaceuticals in reaching global markets, covering regulatory submissions, marketing authorization, logistics, and after‑sales support.

  • Country/Region:
    China
  • Founded:
    2018
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
Chemical Development
Contract Manufacturer
Contract Research Organisation
Pharmaceutical Company (generic finished products)
Contact info
  • No. 617, Fenghuang Road,, Shuangliu District,, 610200, Chengdu, Sichuan, China
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Zennova Pharmaceuticals(Chengdu)Co.,Ltd (1)

  • Pramipexole Hydrochloride

    Product Pramipexole Hydrochloride

    Pramipexole dihydrochloride is a non-ergot dopamine agonist indicated for the treatment of:

    • Parkinson's disease (PD)

    Moderate-to-severe primary Restless Legs Syndrome (RLS)